Dissertation > Excellent graduate degree dissertation topics show

The Investigation of Relationship between Therapeutic Effect and Prognosis and Changes of Peripheral Blood Vascular Endothelial Growth Factor and Metallothionein in Patients with Advanced Lung Cancer

Author: XingShiYun
Tutor: YangWeiBing
School: Zunyi Medical College,
Course: Internal Medicine
Keywords: Lung Cancer Vascular endothelial growth factor Metallothionein
CLC: R734.2
Type: Master's thesis
Year: 2011
Downloads: 5
Quote: 0
Read: Download Dissertation


Objective : To investigate the peripheral blood of patients with advanced lung cancer combined detection of vascular endothelial growth factor (vascular endothelial growth factor, VEGF) and metallothionein (Metallothionein, MT) and histological type of lung cancer , lymph node metastasis, treatment , prognosis relationships. Methods: The experiment was divided into lung cancer ( 33 cases of advanced lung cancer patients ) and control group ( 30 healthy ) ; using double antibody sandwich (ABC-ELISA) method for the determination Serum levels of VEGF and MT ; real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) method were detected VEGF mRNA in peripheral blood mononuclear cells and MT mRNA expression . Results: The serum VEGF, MT levels were (174.3 ± 60.1) pg / ml, (5.7 ± 2.8) ng / ml, lung cancer patients before chemotherapy, VEGF, MT levels were (401.2 ± 142.4) pg / ml, ( 13.9 ± 6.0) ng / ml, lung cancer patients before chemotherapy serum VEGF and MT were significantly higher (P lt; 0.01). Control group blood VEGF mRNA, MT mRNA expression were (48.8 ± 24.1), (95.0 ± 30.3), lung cancer patients before chemotherapy, blood VEGF mRNA, MT mRNA were (209.6 ± 90.3), (184.2 ± 103.2) lung cancer patients before chemotherapy, blood VEGF mRNA, MT mRNA expression were significantly higher (P lt; 0.01). Lung cancer patients after chemotherapy VEGF protein levels below before chemotherapy (P lt; 0.05), while VEGF mRNA in peripheral blood before and after chemotherapy, no difference (P gt; 0.05); MT protein and mRNA in peripheral blood before and after treatment no difference (P gt; 0.05). VEGF and the MT gene and protein expression levels in patients with advanced lung cancer, gender, histological type, lymph node metastasis and efficacy were not correlated , the difference was not statistically significant (P gt; 0.05). MT VEGF in lung cancer group and the positive rates were 78.8% and 63.6% , two kinds of combined detection of tumor markers positive rate rose to 91%. Serum VEGF and MT was no correlation between the measured values ??. Conclusion: Serum VEGF and MT joint detection can increase the positive rate, but no correlation between the two . VEGF, MT joint detection with advanced lung cancer patients gender, histological type, lymph node metastasis , treatment and prognosis of no relevance.

Related Dissertations

  1. The Clinical Research for the Effect of Iodine-125 Seeds Implanted in Advanced Bronchial Lung Cancer,R734.2
  2. Study on the Accumulation and Remove of Cadmium and Lead in Oysters,X174
  3. The Expression of MMP-2、 VEGF and Ki-67 and Human Glioma Grade,R739.41
  4. Effects of 5-Aza-2-deoxycytidine on DNA Methylation and Expression of p16 and MGMT Gene in Lung Cancer Cell Line SPC-A-1,R734.2
  5. Methylation of p16 Gene in Plasma and Tissues from Non-small Cell Lung Cancer Patients, Demethylation and the Biological Behavior of Lung Cancer Cell and Transcription of p16 Gene,R734.2
  6. The Clinical Value of Detection of Serum TPS, CEA, CYFRA21-1, NSE for Diagnosis in Patients with Lung Cancer,R734.2
  7. Study on the Expression and Correlation of Metallothionein and Matrix Metalloproteinase-2 in Non-small Cell Lung Cancer,R734.2
  8. Construction and Application of the Transgenic Yeast Strain Expressing Metallothionein,Q78
  9. The Research on Treatment of Lentivirus-mediated hVEGF-165 Gene Transferring Mesenchymal Stem Cells on Rat Hind Limb Ischemia,R329
  10. The Effect of RNA Interference-mediated ERCC1 Gene on the Chemo-treatment Sensitivity of NSCLC in Vitro,R734.2
  11. Non-small Cell Lung Cancer Analysis of 133 Cases of CVATS Lobectomy,R734.2
  12. Clinical Observation of Pemetrexed for Treating Advanced Non-small Cell Lung Cancer,R734.2
  13. Combined Detection of Tumor Markers in the Diagnosis and Treatment of Lung Cancer to Determine the Clinical Significance,R734.2
  14. Exploreing the Mechanism of Xieshifeiaifang Ii on Treating Lung Cancer with Pleura Effusion,R734.2
  15. BMP2 and VEGF165 Genes Transfected Rat Bone Marrow Mesechymal Stem Cells Simultaneity Expression,R329
  16. Expression of TNF-α, MMP-9 and VEGF in BALF of Rats with Emphysema and Their Mutual Relationship,R563.3
  17. Influence and Significance of MMP-2 and VEGF of Hemangioma Endothelial Cells in Vitro Culture by Propranolol,R739.5
  18. The Analysis of the M8000/3 Coder of the Lung Cancer Case in a Hospital Between 2006 to 2010,R734.2
  19. Expression of Chemokine Receptor CCR5 in Human Non-small-cell Lung Cancer,R734.2
  20. Enhancing Effect of Newcastle Disease Virus in Combination with Chemotherapy for Patients with Advanced Non-small Cell Lung Cancer,R734.2

CLC: > Medicine, health > Oncology > Respiratory system tumors > Lung tumors
© 2012 www.DissertationTopic.Net  Mobile